CP
BNTX icon

CenterBook Partners’s BioNTech BNTX Stock Holding History

CenterBook Partners’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.4M Buy
251,083
+79,917
+47% +$7.52M 1.15% 15
2026
Q1 		$15.2M Sell
171,166
-65,009
-28% -$6.68M 0.82% 19
2025
Q4 		$22.5M Buy
236,175
+50,684
+27% +$5.11M 1.1% 14
2025
Q3 		$18.3M Sell
185,491
-30,453
-14% -$3.26M 0.9% 18
2025
Q2 		$23M Buy
215,944
+106,527
+97% +$10.8M 1.28% 12
2025
Q1 		$9.96M Sell
109,417
-84,701
-44% -$9.48M 0.63% 29
2024
Q4 		$22.1M Buy
194,118
+74,656
+62% +$8.52M 1.32% 9
2024
Q3 		$14.2M Sell
119,462
-86,772
-42% -$7.98M 0.87% 22
2024
Q2 		$16.6M Buy
+206,234
New +$18.9M 1.03% 6

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

CenterBook Partners's BNTX Position: Q2 2026 in Review

CenterBook Partners increased its BioNTech (BNTX) stake by 47% in Q2 2026, buying an estimated $7.52M and bringing the position to 251,083 shares worth $23.4M. The position accounts for 1.15% of the portfolio, ranked #15.

CenterBook Partners first reported a position in BNTX in Q2 2024 and has held it in 9 quarters since. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • CenterBook Partners held 251,083 shares of BioNTech worth $23.4M as of Q2 2026.
  • CenterBook Partners bought 79,917 BioNTech shares in Q2 2026, an estimated $7.52M.
  • BioNTech made up 1.15% of CenterBook Partners's portfolio in Q2 2026, its #15 holding.
  • CenterBook Partners first reported a position in BioNTech in Q2 2024 and has held it in 9 quarters since.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.